연구동향 분석

Can BAP1 expression loss in mesothelial cells be an indicator of malignancy?

Hanife Gulnihal Ozdemir Sermin Coban Kokten Nagehan Ozdemir Barisik 2020년

논문상세정보
인용/피인용
' Can BAP1 expression loss in mesothelial cells be an indicator of malignancy?' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • BAP1
  • asbestosis
  • immunohistochemistry
  • malignantmesothelioma
  • pleura
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
206 0

0.0%

' Can BAP1 expression loss in mesothelial cells be an indicator of malignancy?' 의 참고문헌

  • Utility of survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia
    Kushitani K [2018]
  • Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma
    Wu D [2017]
  • The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium : a novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, Pglycoprotein and Bcl-2
    Attanoos RL [2003]
  • The pathogenesis of mesothelioma
    Carbone M [2006]
  • The frequency of p53 immunostaining in asbestos-associated mesotheliomas and non-asbestos-associated mesotheliomas
    Mayall FG [1993]
  • The diagnostic value of Ki-67 and repp86 in distinguishing between benign and malignant mesothelial proliferations
    Taheri ZM [2008]
  • Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease : a systematic review of published reports
    King J [2006]
  • Pathology of the pleura : what the pulmonologists need to know
    Cagle PT [2011]
  • Malignant mesothelioma, BAP1 immunohistochemistry, and VEGFA : does BAP1 have potential for early diagnosis and assessment of prognosis
    Pulford E [2017]
  • Loss of BRCA1-associated protein 1(BAP1)expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions
    Cozzi I [2018]
  • Loss of BAP1 function leads to EZH2-dependent transformation
    LaFave LM [2015]
  • Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis : comparison with 9p21 FISH and BAP1 immunohistochemistry
    Hida T [2017]
  • Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma : a secondary publication
    Hjerpe A [2015]
  • Environmental mesothelioma in Turkey
    Baris YI [1979]
  • Distinguishing benign mesothelial hyperplasia from neoplasia : a practical approach
    Kradin RL [2006]
  • Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies
    Cagle PT [2005]
  • Diagnostic value of BRCA1-associated protein-1, glucose transporter-1and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions
    Onder S [2019]
  • Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma
  • Biologic, cytogenetic, and molecular factors in mesothelial proliferations
    Hicks J [2006]
  • BAP1(BRCA1-associated protein 1)is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
  • BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma
    Lee HE [2018]
  • BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A(p16)fluorescence in situ hybridization in malignant pleural mesothelioma
    McGregor SM [2017]
  • BAP1 Immunostain and CDKN2A(p16)FISH analysis : clinical applicability for the diagnosis of malignant mesothelioma in effusions
    Walts AE [2016]